Namandje N Bumpus

Associate Professor

20042019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Namandje N Bumpus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Biotransformation and bioactivation reactions–2018 literature highlights

Khojasteh, S. C., Bumpus, N. N., Driscoll, J. P., Miller, G. P., Mitra, K., Rietjens, I. M. C. M. & Zhang, D., Jan 1 2019, (Accepted/In press) In : Drug Metabolism Reviews.

Research output: Contribution to journalReview article

  • Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities

    Zhang, D., Hop, C. E. C. A., Patilea-Vrana, G., Gampa, G., Seneviratne, H. K., Unadkat, J. D., Kenny, J. R., Nagapudi, K., Di, L., Zhou, L., Zak, M., Wright, M. R., Bumpus, N. N., Zang, R., Liu, X., Lai, Y. & Cyrus Khojasteh, S., Jan 1 2019, In : Drug Metabolism and Disposition. 47, 10, p. 1122-1135 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • Efavirenz and efavirenz-like compounds activate human, murine, and macaque hepatic IRE1a-XBP1

    Heck, C. J. S., Hamlin, A. N. & Bumpus, N. N., Feb 1 2019, In : Molecular Pharmacology. 95, 2, p. 185-195 11 p.

    Research output: Contribution to journalArticle

  • Genetic variation of kinases and activation of nucleotide analog reverse transcriptase inhibitor tenofovir

    Hamlin, A. N., Tillotson, J. & Bumpus, N. N., Jan 1 2019, In : Pharmacogenomics. 20, 2, p. 105-111 7 p.

    Research output: Contribution to journalArticle